80866-79-1

Usage

Appearance

White crystalline powder

Molecular weight

216.7 g/mol

Pharmaceutical industry

Used as an intermediate in the synthesis of various medications and organic compounds.

Research

Used in the study of its potential use in the treatment of pain and inflammation.

Analgesic

Possesses pain-relieving properties.

Anti-inflammatory

Exhibits properties that help reduce inflammation.

Enzyme inhibition

Known to inhibit both cyclooxygenase and lipoxygenase enzymes, which are involved in the production of inflammatory mediators.

Potential use in pharmaceutical development

Due to its enzyme inhibition properties, it may be useful in the development of new pharmaceuticals.

Applications in organic chemistry

May be used as a building block in the synthesis of other chemical compounds, making it a versatile compound for various industries.

InChI:InChI=1/C12H15ClO/c13-11-5-3-10(4-6-11)12(9-14)7-1-2-8-12/h3-6,14H,1-2,7-9H2

Upstream product

• 80789-69-1 1-(4-chlorophenyl)cyclopentane-1-carboxylic acid 
• 64399-26-4 1-(4-chlorophenyl)cyclopentanecarboxylic acid 
• 140-53-4 p-chlorobenzyl cyanide 
• 189810-98-8 1-(4-chlorophenyl)cyclopentane-1-carbaldehyde 
• 914106-85-7 1-(4-chlorophenyl)-1-cyclopentanecarboxylic acid methyl ester 

Downstream Products

• 189810-98-8 1-(4-chlorophenyl)cyclopentane-1-carbaldehyde 
• 1616922-78-1 [1-(4-chlorophenyl)cyclopentyl]acetonitrile 
• 1616922-77-0 methanesulfonic acid 1-(4-chlorophenyl)cyclopentylmethyl ester 
• 162780-92-9 <1-(p-Chlorophenyl)cyclopentyl>carbinyl tosylate 

Relevant academic research and scientific papers

THIAZOLIDINONE COMPOUNDS AND USE THEREOF

A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.

PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.

5[W(substituted aryl)alkenylene and alkynylene]-2,4-diaminopyrimidines as pesticides

5-Substituted-2,4-diaminopyrimidines, and agriculturally acceptable salts thereof, when present in insecticidally or acaricidally effective amounts, and with a suitable agricultural carrier, are useful as active ingredients in novel insecticidal and acaricidal compositions. These pyrimidines may be represented by the following formula: STR1 wherein Ar is STR2 and wherein U is an alkenylene or alkynylene moiety, and R, R1, R2, R3, R4, V, W, X, Y, Z and n are as defined herein; also disclosed and claimed are novel intermediates thereof.